Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 2 |
2017 | 2 |
2018 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Tapping the RNA world for therapeutics.
Nat Struct Mol Biol. 2018 May;25(5):357-364. doi: 10.1038/s41594-018-0054-4. Epub 2018 Apr 16.
Nat Struct Mol Biol. 2018.
PMID: 29662218
Free PMC article.
Review.
Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer.
Su S, Liao J, Liu J, Huang D, He C, Chen F, Yang L, Wu W, Chen J, Lin L, Zeng Y, Ouyang N, Cui X, Yao H, Su F, Huang JD, Lieberman J, Liu Q, Song E.
Su S, et al.
Cell Res. 2017 Apr;27(4):461-482. doi: 10.1038/cr.2017.34. Epub 2017 Mar 14.
Cell Res. 2017.
PMID: 28290464
Free PMC article.
Item in Clipboard
Knocking down disease: a progress report on siRNA therapeutics.
Wittrup A, Lieberman J.
Wittrup A, et al.
Nat Rev Genet. 2015 Sep;16(9):543-52. doi: 10.1038/nrg3978.
Nat Rev Genet. 2015.
PMID: 26281785
Free PMC article.
Review.
Item in Clipboard
Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown.
Zhang Y, Xie X, Yeganeh PN, Lee DJ, Valle-Garcia D, Meza-Sosa KF, Junqueira C, Su J, Luo HR, Hide W, Lieberman J.
Zhang Y, et al.
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):e2022830118. doi: 10.1073/pnas.2022830118.
Proc Natl Acad Sci U S A. 2021.
PMID: 33627408
Free PMC article.
Item in Clipboard
Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells.
Gilboa-Geffen A, Hamar P, Le MT, Wheeler LA, Trifonova R, Petrocca F, Wittrup A, Lieberman J.
Gilboa-Geffen A, et al.
Mol Cancer Ther. 2015 Oct;14(10):2279-91. doi: 10.1158/1535-7163.MCT-15-0201-T. Epub 2015 Aug 11.
Mol Cancer Ther. 2015.
PMID: 26264278
Item in Clipboard
Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival.
Chan S, Sridhar P, Kirchner R, Lock YJ, Herbert Z, Buonamici S, Smith P, Lieberman J, Petrocca F.
Chan S, et al.
Mol Cancer Ther. 2017 Dec;16(12):2849-2861. doi: 10.1158/1535-7163.MCT-17-0461. Epub 2017 Sep 6.
Mol Cancer Ther. 2017.
PMID: 28878028
Free PMC article.
Item in Clipboard
Cite
Cite